Invesco
SANA icon

Invesco’s Sana Biotechnology SANA Stock Holding History

Invesco’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.76M Sell
504,262
-64,924
-11% -$209K ﹤0.01% 2646
2026
Q1 		$1.64M Buy
569,186
+7,351
+1% +$29K ﹤0.01% 2636
2025
Q4 		$2.29M Buy
561,835
+109,078
+24% +$488K ﹤0.01% 2560
2025
Q3 		$1.61M Buy
452,757
+179,776
+66% +$650K ﹤0.01% 2713
2025
Q2 		$745K Buy
272,981
+107,335
+65% +$221K ﹤0.01% 2983
2025
Q1 		$278K Buy
165,646
+117,144
+242% +$327K ﹤0.01% 3385
2024
Q4 		$79.1K Buy
48,502
+1,322
+3% +$3.94K ﹤0.01% 3651
2024
Q3 		$196K Buy
47,180
+896
+2% +$4.71K ﹤0.01% 3522
2024
Q2 		$253K Buy
46,284
+5,200
+13% +$41.4K ﹤0.01% 3548
2024
Q1 		$411K Sell
41,084
-72,310
-64% -$542K ﹤0.01% 3416
2023
Q4 		$463K Buy
113,394
+8,479
+8% +$31.2K ﹤0.01% 3266
2023
Q3 		$406K Buy
104,915
+1,383
+1% +$7.43K ﹤0.01% 3307
2023
Q2 		$617K Sell
103,532
-3,370
-3% -$19.4K ﹤0.01% 3132
2023
Q1 		$350K Buy
106,902
+68,675
+180% +$274K ﹤0.01% 3448
2022
Q4 		$151K Sell
38,227
-227
-0.6% -$1.11K ﹤0.01% 3759
2022
Q3 		$231K Sell
38,454
-711,744
-95% -$5.14M ﹤0.01% 3628
2022
Q2 		$4.82M Buy
750,198
+713,005
+1,917% +$4.54M ﹤0.01% 2305
2022
Q1 		$307K Buy
37,193
+1,280
+4% +$10.3K ﹤0.01% 3630
2021
Q4 		$556K Buy
35,913
+6,184
+21% +$119K ﹤0.01% 3347
2021
Q3 		$669K Buy
+29,729
New +$624K ﹤0.01% 3292
2021
Q2 		– Sell
-24,633
Closed -$824K – 4025
2021
Q1 		$824K Buy
+24,633
New +$802K ﹤0.01% 3125

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Invesco's SANA Position: Q2 2026 in Review

Invesco reduced its Sana Biotechnology (SANA) stake by 11% in Q2 2026, selling an estimated $209K and leaving 504,262 shares worth $1.76M. The position accounts for ﹤0.01% of the portfolio, ranked #2646.

Invesco first reported a position in SANA in Q1 2021 and has held it in 21 quarters since. The position peaked at $4.82M in Q2 2022. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • Invesco held 504,262 shares of Sana Biotechnology worth $1.76M as of Q2 2026.
  • Invesco sold 64,924 Sana Biotechnology shares in Q2 2026, an estimated $209K.
  • Sana Biotechnology made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #2646 holding.
  • Invesco first reported a position in Sana Biotechnology in Q1 2021 and has held it in 21 quarters since.
  • Invesco's Sana Biotechnology position peaked at $4.82M in Q2 2022.
  • 211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.